Lavino Francesco Maria 4
4 · Nabriva Therapeutics plc · Filed Feb 4, 2020
Insider Transaction Report
Form 4
Lavino Francesco Maria
Chief Commercial Officer
Transactions
- Tax Payment
Ordinary Shares
2020-01-31$1.35/sh−3,892$5,254→ 75,830 total
Holdings
- 79,722
Ordinary Shares
Footnotes (1)
- [F1]The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 63,750 previously reported restricted stock units and 15,972 ordinary shares.